HIGHLIGHTS
- who: Niels Hansen from the Santa Maria Nuova Hospital, Italy Virginia Commonwealth University have published the research: Case report: Amnestic mild cognitive impairment in multiple domains associated with neurofascin 186 autoantibodies: Case series with follow-up and review, in the Journal: (JOURNAL)
- what: The authors report two patients predominantly presenting with cognitive impairment as a clinical phenotype in which primary neuroinflammatory locus is probably not the peripheral nervous system.
SUMMARY
L-thyroxin 50 mikrog/d, fexofenadin 180 mg/d and bupropion 150 mg/d. She was also suffering from depression (ICD . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.